Immix Biopharma, Inc. Immix Biopharma Announces Early Positive IMX-110 Interim Clinical Trial Data Demonstrating 100% Tumor Shrinkage in Advanced Metastatic Colorectal Cancer at the Lowest Dose of ...

Immutable X (IMX) hopes to solve it by creating a layer-2 solution for Ethereum. Specifically, it is looking to reduce high fees in the Ethereum non-fungible token (NFT) space.

IMX saw a slight bump up in its price following the listing, before being dragged down with the wider market as the price of Bitcoin dropped to a low near $33,500 on Jan. 24.

100% Tumor Shrinkage at 2-months in advanced metastatic colorectal cancer was demonstrated by IMX-110 + BeiGene / Novartis anti-PD-1 Antibody Tislelizumab combination in the first, lowest dose ...

100% of patients treated with IMX-110 completed planned treatment cycles without drug-related interruptions in its ongoing Phase 1b/2a clinical trial IMX-110 is in clinical development as a ...